686320-24-1

Basic information

• Product Name: 4-Oxazolidineacetic acid, 2-oxo-4-phenyl-, methyl ester
• CAS NO: 686320-24-1
• Molecular Formula: C12H13NO4
• Molecular Weight: 235.24
• Mol File: 686320-24-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 4-Oxazolidineacetic acid, 2-oxo-4-phenyl-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Oxazolidineacetic acid, 2-oxo-4-phenyl-, methyl ester(686320-24-1)
• EPA Substance Registry System: 4-Oxazolidineacetic acid, 2-oxo-4-phenyl-, methyl ester(686320-24-1)

Safety Data

• Hazardous Substances Data: 686320-24-1(Hazardous Substances Data)

Upstream product

• 2835-06-5 phenylglycin 
• 144073-04-1 (RS)-2-amino-2-phenyl-4-penten-1-ol 
• 142035-33-4 ethyl N-(phenylmethylene)glycinate 
• 67-56-1 methanol 

Downstream Products

• 686320-25-2 C₁₈H₂₃NO₆ 
• 686320-27-4 6-(2,5-difluorophenyl)-7a-phenyl-5,7a-dihydro-1H-pyrrolo[1,2-c][1,3]oxazole-3-one 
• 845256-48-6 (2S)-4-(2,5-difluorophenyl)-2-phenyl-2-[(1,1,2,2-tetramethylpropoxy)methyl]-2,5-dihydro-1H-pyrrole 
• 686320-26-3 7a-phenyldihydro-1H-pyrrolo[1,2-c][1,3]oxazole-3,6(5H)-dione 
• 845256-78-2 (2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoropiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide 
• 686320-28-5 4-(2,5-difluorophenyl)-2-phenyl-2-[(1,1,2,2-tetramethylpropoxy)methyl]-2,5-dihydro-1H-pyrrole 
• 845256-49-7 (2S)-2-({[tert-butyl(dimethyl)silyl]oxy}methyl)-4-(2,5-difluorophenyl)-2-phenyl-2,5-dihydro-1H-pyrrole-1-carbonyl chloride 
• 847041-34-3 benzyl (3R,4S)-4-[{[(2S)-2-({[tert-butyl(dimethyl)silyl]oxy}methyl)-4-(2,5-difluorophenyl)-2-phenyl-2,5-dihydro-1H-pyrrol-1-yl]carbonyl}(methyl)amino]-3-fluoropiperidine-1-carboxylate 
• 847027-69-4 (2S)-4-(2,5-difluorophenyl)-N-[(4R,6S)-6-fluoro-1-methylazepan-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide 
• 847027-70-7 (2S)-4-(2,5-difluorophenyl)-N-[(4S,6R)-6-fluoro-1-methylazepan-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide 

Relevant articles and documents

MITOTIC KINESIN INHIBITORS

The present invention relates to dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

MITOTIC KINESIN INHIBITORS

The present invention relates to dihydropyrrole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention is also related to compositi